Business profile & competitive position
Brown & Brown, Inc. operates as a diversified insurance agency and wholesale brokerage, with additional programs and services focused mainly on property, casualty and employee-benefits products. In its core business it acts as an agent or broker and does not assume underwriting risk, although it also runs ancillary insurance operations such as captives, reinsurance companies and Wright National Flood Insurance Company. Related services include risk management, loss-control surveys and claims processing. As of December 31, 2025, the company ran 468 domestic locations across 47 states and 246 international locations across 15 named countries.
The revenue mix as of 2025 highlights two reporting segments. Retail generated $3,386 million in commissions and fees, or 58.7% of the total. Specialty Distribution—which includes the consolidated Programs and Wholesale Brokerage segments following the Q3 2025 RSC/Accession acquisition—produced $2,379 million, or 41.3%. International operations have grown steadily, contributing $843 million in 2025, up from $665 million in 2024 and $527 million in 2023.
A 17.6% net margin and a 9.6% ROE are the figures that matter when judging competitive strength. The double-digit net margin reflects the broker model’s ability to collect recurring commissions without carrying most of the underwriting volatility of an insurer. The ROE, while modest relative to leveraged financials, is consistent with an asset-light intermediary model and suggests returns are driven more by distribution relationships and fee-based revenue than by balance-sheet risk. The geographic footprint and segment diversity help insulate the top line from any single state market or product line.
Financial posture
Brown & Brown carries a market capitalization of roughly $21.0 billion and trades at a P/E of 17.4. The beta of 0.59 implies the stock historically moves less than the overall market, which fits the defensive, fee-and-commission profile of an insurance broker. Net margin sits at 17.6% and ROE at 9.6%. The current share price is $62.88, below the 50-day exponential moving average of $65.46, while the relative-strength index is 45.5—neither overbought nor oversold on the standard 14-day reading.
Valuation at 17.4 times earnings sits in the zone where investors are paying a moderate premium for stability and recurring cash flow, but not an extreme multiple. Low beta and high single-digit ROE together paint the picture of a capital-light compounder rather than a high-growth disruptor. The company does not assume material underwriting risk in its core operations, which helps explain why margins remain elevated even when insurance pricing cycles shift.
Strategic priorities & outlook
The company’s most recent 10-K filing emphasizes realizing the anticipated benefits, synergies and growth opportunities from the RSC/Accession acquisition as a top priority. That deal also prompted a structural change: Brown & Brown consolidated its Programs and Wholesale Brokerage segments into a single Specialty Distribution segment, so going forward the company reports through Retail and Specialty Distribution.
Operationally, management describes the target state as a high-performing, decentralized organization with a customer-first approach focused on growth and service. Talent development is a recurring theme, supported by programs such as Brown & Brown University, mentorship programs, college partnerships and internships. The company also points to culture initiatives tied to its Diversity, Inclusion and Belonging advisory council and Teammate Resource Groups as part of its broader effort to attract and retain producers and support staff in a relationship-driven industry.
Macro & geopolitical exposure
As a Financial Services company in the Insurance - Brokers industry, Brown & Brown is exposed to the structural drivers of the broader insurance intermediary space. Interest-rate levels affect investment income on held funds and the cost of capital for larger clients, which can influence pricing across commercial lines. State-by-state insurance regulation shapes commission structures, licensing requirements and marketplace competition, while federal rules around employee benefits influence demand for benefits-brokerage services. Property-catastrophe activity and reinsurance pricing cycles can push premiums higher across property-casualty markets, which can increase commission dollars but may also increase client sensitivity to cost. International operations, which produced $843 million in 2025, add currency translation and cross-border regulatory exposure to the risk profile.
Recent developments
The most recent news flow has centered on institutional accumulation and workplace recognition. On October 9, 2026, defenseworld.net reported that GAMMA Investing LLC boosted its $BRO stock holdings. On October 8, 2026, globenewswire.com reported that Brown & Brown was named one of the 2026 Healthiest 100 Workplaces in America®. Earlier that week, on October 6, 2026, MassMutual Private Wealth & Trust FSB purchased 93,747 shares of Brown & Brown stock, according to defenseworld.net, and on October 5, 2026, Park National Corp OH purchased 46,031 shares, also per defenseworld.net. These items illustrate ongoing institutional attention but do not by themselves imply a directional outlook.
Earnings behavior & post-earnings drift
Over the last eight reported quarters, Brown & Brown beat analyst EPS estimates six times, for a beat rate of 86%. The average earnings surprise during that span was 4.4%. Despite that strong headline record, the average five-trading-day price move following earnings was -7.91%, classified as a downward post-earnings drift.
The last four quarters show the disconnect in detail. On October 27, 2025, the company reported EPS of $1.05 against an estimate of $0.944, an 11.2% positive surprise, yet the stock fell 6.13% the next day and 11.33% over the following five sessions. On January 26, 2026, EPS of $0.93 beat the $0.905 estimate by 2.8%, and the stock still dropped 6.91% the next day and 10.45% over five days. On April 27, 2026, EPS of $1.39 beat the $1.36 estimate by 2.2%, with the stock down 4.51% the next day and down 12.83% over five sessions. The most recent report, on July 27, 2026, was the exception in direction: EPS of $1.07 missed the $1.08 estimate by 0.9%, but the stock rose 5.67% the next day and 2.98% over the following five sessions.
This pattern means a beat has not reliably led to a sustained price pop, and the unofficial consensus has at times been more demanding than the published estimate. With the next report scheduled for October 26, 2026, after the close and the current consensus EPS estimate at $1.09, traders should weigh the historical -7.91% average five-day drift alongside the 86% beat rate when shaping expectations around the print.
Frequently Asked Questions
What is Brown & Brown's core business model?
Brown & Brown is a diversified insurance agency, wholesale brokerage and programs/services organization focused on property, casualty and employee benefits. It primarily acts as an agent or broker without assuming underwriting risk, while also running ancillary insurance operations such as captives, reinsurance companies and Wright National Flood Insurance Company.
Why has BRO's stock tended to fall after earnings even when it beats estimates?
Over the last eight quarters the company has beaten estimates 86% of the time with an average surprise of 4.4%, but the average five-day post-earnings drift was -7.91%. The last three beat quarters before July 2026 posted negative five-day moves, suggesting that the market's real expectation sometimes ran ahead of the published consensus and that positive surprises were already priced in.
When is Brown & Brown reporting next, and what is the consensus estimate?
The next scheduled earnings release is October 26, 2026, after the market close, with a current consensus EPS estimate of $1.09.
For a fuller picture of how sell-side and institutional investors are interpreting the RSC/Accession integration, margin trajectory and upcoming earnings setup, readers should review the complete institutional verdict rather than relying on headline numbers alone.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-27 | $1.07 | $1.08 | -0.9% | +5.67% | +2.98% |
| 2026-04-27 | $1.39 | $1.36 | +2.2% | -4.51% | -12.83% |
| 2026-01-26 | $0.93 | $0.905 | +2.8% | -6.91% | -10.45% |
| 2025-10-27 | $1.05 | $0.944 | +11.2% | -6.13% | -11.33% |
| 2025-07-28 | $1.03 | $0.986 | +4.5% | - | - |
| 2025-04-28 | $1.29 | $1.29 | 0% | - | - |
Previous BRO editions
Get the institutional verdict on BRO
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the BRO verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.